Insider Transactions

What Avidity Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	18
Total trades	0	55

Shares traded

	3 months	12 months
Acquired	0	320,750
Disposed	0	1,919,098
Net activity	+0	−1,598,348

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Kaye Edward M. Md	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
Mosbrooker Eric	Chief Commercial Officer	Feb 27	Disposition to Issuer · D	−79,413	—	—	0
Kim Jean Jinsun	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
Gallagher Kathleen P.	Chief Program Officer	Feb 27	Disposition to Issuer · D	−80,303	—	—	0
Flanagan W. Michael	Chief Scientific Officer	Feb 27	Disposition to Issuer · D	−150,365	—	—	0
Hughes Steven George	Chief Medical Officer	Feb 27	Disposition to Issuer · D	−115,857	—	—	0
Henig Noreen	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
McCarthy Teresa	Chief Human Resources Officer	Feb 27	Disposition to Issuer · D	−165,296	—	—	0
Calderaro Charles Iii	Chief Technical Officer	Feb 27	Disposition to Issuer · D	−98,547	—	—	0
Boess Carsten	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
Levin Arthur A	Director	Feb 27	Disposition to Issuer · D	−131,372	—	—	0
Levin Arthur A	Director	Feb 27	Disposition to Issuer · D	−16,562	—	—	0
Moriarty John B	Chief Legal Officer	Feb 27	Disposition to Issuer · D	−92,054	—	—	0
Wilson Troy Edward	Director	Feb 27	Disposition to Issuer · D	−13,711	—	—	0
Wilson Troy Edward	Director	Feb 27	Disposition to Issuer · D	−65,091	—	—	0
Boyce Sarah	President and CEO	Feb 27	Disposition to Issuer · D	−474,861	—	—	0
Skerjanec Simona	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
MacLean Michael F	Chief Financial Officer	Feb 27	Disposition to Issuer · D	−133,977	—	—	0
Thompson Tamar	Director	Feb 27	Disposition to Issuer · D	−6,692	—	—	0
Flanagan W. Michael	Chief Scientific Officer	Jan 21	Sale for tax withholding · S	−2,558	$72.45	−$185K	85,093

Page 1 of 18 · showing the 20 most recent Sign up free to view all 346 transactions and filter by insider →

Comments